维普中文期刊产品整合服务
217篇 您的检索式:作者名="Majeti"
    题名 作者 年代 出处 被引量
1Undiagnosed Hoffa fracture of medial femoral condyle presenting as chronic pain in a post-polio limb显示文摘有未经触动的侧面的大腿骨的髁的中间的大腿骨的髁的孤立的花冠骨折是极其稀罕的。怀疑的一个高索引在 undisplaced 破裂的情况下特别为早诊断是必要的。这里,我们在作为长期的疼痛介绍的脊髓灰质炎以后的手足报导中间的 Hoffa 骨折的一个案例。鉴于骨质疏松症和骨状的发育不全,在脊髓灰质炎的迟了的 sequelae 影响的手足的如此的破裂的管理是特别地有问题的。破裂通过中间的 parapatellar 关节切开术被接近,固定在 anteroposterior 方向用完了 cannulated cancellous 螺丝钉。联合在 16   被完成;星期。Aditya Krishna Mootha Priyanka Majety Vishal Kumar 2014Chinese Journal of Traumatology2014,17,3:4
2A review of chitin and chitosan applications显示文摘Majeti N.V Ravi Kumar 2000Reactive and Functional Polymers2000,,1:3
3Current understandings of the pathogenesis of type 1 diabetes:Genetics to environment显示文摘Type 1 diabetes(T1D)is an autoimmune disease that usually strikes early in life,but can affect individuals at almost any age.It is caused by autoreactive T cells that destroy insulin-producing beta cells in the pancreas.Epidemiological studies estimate a prevalence of 1 in 300 children in the United States with an increasing incidence of 2%-5%annually worldwide.The daily responsibility,clinical management,and vigilance required to maintain blood sugar levels within normal range and avoid acute complications(hypoglycemic episodes and diabetic ketoacidosis)and long term micro-and macro-vascular complications significantly affects quality of life and public health care costs.Given the expansive impact of T1D,research work has accelerated and T1D has been intensively investigated with the focus to better understand,manage and cure this condition.Many advances have been made in the past decades in this regard,but key questions remain as to why certain people develop T1D,but not others,with the glaring example of discordant disease incidence among monozygotic twins.In this review,we discuss the field’s current understanding of its pathophysiology and the role of genetics and environment on the development of T1D.We examine the potential implications of these findings with an emphasis on T1D inheritance patterns,twin studies,and disease prevention.Through a better understanding of this process,interventions can be developed to prevent or halt it at early stages.Adebola Matthew Giwa Rizwan Ahmed Zahra Omidian Neha Majety Kagan Ege Karakus Sarah M Omer Thomas Donner Abdel Rahim A Hamad 2020World Journal of Diabetes2020,11,1:2
4CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis显示文摘Siddhartha Jaiswal Catriona H.M. Jamieson Wendy W. Pang Christopher Y. Park Mark P. Chao Ravindra Majeti David Traver Nico van Rooijen Irving L. Weissman 2009Cell2009,,2:2
5CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells显示文摘Ravindra Majeti Mark P. Chao Ash A. Alizadeh Wendy W. Pang Siddhartha Jaiswal Kenneth D. Gibbs Nico van Rooijen Irving L. Weissman 2009Cell2009,,2:2
6A review of chitin and chitosan applications显示文摘Majeti N.V Ravi Kumar 2000Reactive and Functional Polymers2000,,1:2
7Nature:利用CRISPR/Cas9治疗镰状细胞疾病取得重大进展显示文摘在一项新的研究中,来自美国斯坦福大学医学院的研究人员利用一种被称作CRISPR/Cas9的基因编辑工具修复人干细胞中导致镰状细胞疾病的基因。这是开发一种治疗这种疾病的基因疗法的关键一步。相关研究结果在线发表在Nature期刊上。Daniel P. Dever, Rasmus O. Bak, Joab Camarena, Gabriel Washington, Carmencita E. Nicolas, Mara Pavel-Dinu, Nivi Saxena, Alec B. Wilkens, Sruthi Mantri, Ayal Hendel, Kenneth I. Weinberg Matthew H. Porteus Andreas Reinisch Ravindra Majeti Nobuko Uchida Anupama Narla 2016现代生物医学进展2016,16,35:2
8A review of chitin and chitosan 显示文摘Majeti N V Kumar R 2000Reactive and Functional Polymers2000,46,:1
9A review of chitin and chitosan applications 显示文摘Majeti N V Ravi K 2000Reactive and Functional Polymers2000,46,:1
10显示文摘Majeti N V Kumar R 2000Reactive and Functional Polymers2000,46,:1
11A review of chitin and chitosan applications 显示文摘Majeti N V Ravi Kumar 2000Reactive & Functional Polymers2000,46,:1
12A review of chitin and chitosan applica- tions显示文摘MAJETI N V KUMAR R 2000Reactive and Functional Polymers2000,46,01:1
13CD47 is an adverse prog? nostic factor and therapeutic antibody target on human acute my?eloid leukemia stem cells显示文摘Majeti R Chao MP Alizadeh AA 2009Cell2009,138,2:1
14CD47 is an adverse prog- nostic factor and therapeutic antibody target on human acute mye- loid leukemia stem cells显示文摘Majeti R Chao MP Alizadeh AA 2009Cell2009,138,:1
15Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood显示文摘Majeti R Park CY Weissman IL 2007Cell Stem Cell2007,1,6:1
16A Review on Perforation Repair Materials显示文摘Kakani AK Veeramachaneni C Majeti C 2015J Clin Diagn Res2015,9,9:1
17CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells 显示文摘Majeti R Chao MP Alizadeh AA 2009Cell2009,138,2:1
18VEGF is an important me-diator of tumor angiogenesis in malignant lesions in a genetically en-gineered mouse model of lung adenocarcinoma显示文摘Majeti BK Lee JH Simmons BH 2013BMC Cancer2013,13,1:1
19MieroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis显示文摘Anand S Majeti BK Acevedo LM Nature Medicine0,,:1
20CD47 is upregulated on circulating hematopoietie stem cells and leukemia cells to avoid phagoeytosis 显示文摘Jaiswal S Jamieson CH Pang WW Park CY Chao MP Majeti R 2009Cell2009,138,2:1
返回顶部 每页显示:
共11页 首页 上一页 第1页 下一页 末页 /11 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费